Watch My New Episode with Dr. Steve Horvath

Why It Matters

The episode signals that scalable, noninvasive measures like the epigenetic clock can quantify the impact of lifestyle, supplements and psychosocial factors on biological aging, guiding research and potential therapies. If validated, these findings could shift investment and clinical focus toward preventative and social-health interventions to slow age-related decline.

Summary

In a new episode, longevity researcher Dr. Steve Horvath—developer of the landmark Horvath epigenetic clock—discusses what drives aging and evaluates claims of rapid biological age reversal. He cautions that dramatic reversals are unlikely except when major health risks (obesity, inflammation, diabetes) are radically improved, framing aging interventions as primarily preventive. Horvath highlights results from the COSMOS trial showing multivitamin use correlated with a 2.1-year slowing of brain aging, and expresses surprise that mental health and social relationships produced measurable changes in DNA methylation in blood. The conversation underscores both the promise and the complexity of using epigenetic biomarkers to track interventions."